Chris H Takimoto

CIK 1743780 · CHIEF MEDICAL OFFICER · last filed 2026-01-21

Chris H Takimoto is a CHIEF MEDICAL OFFICER who has filed 31 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for ALXO, was dated Jan 21, 2026. Across all open-market trades the lifetime net is −$9.2M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

31

Lifetime Open-Market Net

-$9.18M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALXO Director $1.58 $0 2 2026-01-21
IGM Biosciences, Inc. (IGMS) Delisted CHIEF MEDICAL OFFICER 154,331 $1.27 $196.0K -$277.4K 17 2024-09-17
Forty Seven, Inc. (FTSV) Delisted Chief Medical Officer 0 -$8.90M 12 2020-04-07

Recent Filings

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-01-21 ALXO Grant (A) $0 EDGAR
2025-01-23 ALXO Grant (A) $0 EDGAR
2024-09-17 IGM Biosciences, Inc. (IGMS) Delisted Sell (S) −1,487 -$17.2K EDGAR
2024-07-23 IGM Biosciences, Inc. (IGMS) Delisted Mixed +60,000 $0 EDGAR
2024-06-18 IGM Biosciences, Inc. (IGMS) Delisted Mixed +1,430 $3.2K EDGAR
2024-03-15 IGM Biosciences, Inc. (IGMS) Delisted Sell (S) −5,424 -$54.3K EDGAR
2024-03-14 IGM Biosciences, Inc. (IGMS) Delisted Grant (A) +46,250 $0 EDGAR
2023-12-01 IGM Biosciences, Inc. (IGMS) Delisted Sell (S) −1,180 -$7.3K EDGAR
2023-05-25 IGM Biosciences, Inc. (IGMS) Delisted Mixed −297 -$4.2K EDGAR
2023-04-06 IGM Biosciences, Inc. (IGMS) Delisted Grant (A) +26,250 $0 EDGAR
Showing 110 of 31
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.